We investigated EGFR and HER-2 status in brain metastatic non-small cell lung cancer (NSCLC) and compared them to EGFR and HER-2 status of primary NSCLC Evaluated were 66 cases of brain metastatic NSCLC  including 20 cases of corresponding primary NSCLC